Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Wednesday, August 27, 2008

Harvard makes diabetic cells produce insulin in mice

By Mass High Tech Staff


Researchers at Harvard University have found a technique to develop the pancreatic cells of mice to produce insulin, which could one day aid people with diabetes.

The technique involves cell-fate analysis in which the researchers funneled through 1,400 transcription factors in mice and eventually inserted the diabetic disease carrying genes encoded with three of the factors into the pancreatic cells of the mice, according to a report in the journal Nature. The experiment resulted in 20 percent of the mice switching to insulin-producing pancreatic cells.

The technique was a mixture of luck and experimentation, the researchers said in the journal. However, the pancreatic cell conversion process remains successful after six months since the test.

Douglas Melton, co-author of the article and co-director of the Harvard Stem Cell Institute, would like to apply the cell conversion technique to neurogenerative and liver disorders.

 

 

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your level of interest in Pinterest?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.